JP2011085586A5 - - Google Patents

Download PDF

Info

Publication number
JP2011085586A5
JP2011085586A5 JP2010229934A JP2010229934A JP2011085586A5 JP 2011085586 A5 JP2011085586 A5 JP 2011085586A5 JP 2010229934 A JP2010229934 A JP 2010229934A JP 2010229934 A JP2010229934 A JP 2010229934A JP 2011085586 A5 JP2011085586 A5 JP 2011085586A5
Authority
JP
Japan
Prior art keywords
pct
acute stroke
patient
ischemic attack
bacterial infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010229934A
Other languages
English (en)
Japanese (ja)
Other versions
JP5722587B2 (ja
JP2011085586A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011085586A publication Critical patent/JP2011085586A/ja
Publication of JP2011085586A5 publication Critical patent/JP2011085586A5/ja
Application granted granted Critical
Publication of JP5722587B2 publication Critical patent/JP5722587B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010229934A 2009-10-13 2010-10-12 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス Active JP5722587B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09012947.9 2009-10-13
EP09012947 2009-10-13

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014237837A Division JP2015057611A (ja) 2009-10-13 2014-11-25 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス

Publications (3)

Publication Number Publication Date
JP2011085586A JP2011085586A (ja) 2011-04-28
JP2011085586A5 true JP2011085586A5 (cg-RX-API-DMAC7.html) 2013-05-09
JP5722587B2 JP5722587B2 (ja) 2015-05-20

Family

ID=41362428

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010229934A Active JP5722587B2 (ja) 2009-10-13 2010-10-12 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス
JP2014237837A Withdrawn JP2015057611A (ja) 2009-10-13 2014-11-25 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014237837A Withdrawn JP2015057611A (ja) 2009-10-13 2014-11-25 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス

Country Status (5)

Country Link
US (1) US8383332B2 (cg-RX-API-DMAC7.html)
EP (1) EP2320237B1 (cg-RX-API-DMAC7.html)
JP (2) JP5722587B2 (cg-RX-API-DMAC7.html)
CN (1) CN102081101B (cg-RX-API-DMAC7.html)
ES (1) ES2601104T3 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE533061T1 (de) * 2007-08-03 2011-11-15 Brahms Gmbh Verfahren zur diagnose bakterieller infektionen
ES2601104T3 (es) * 2009-10-13 2017-02-14 B.R.A.H.M.S Gmbh Procalcitonina para el diagnóstico de infecciones bacterianas y la guía del tratamiento antibiótico en pacientes con apoplejía aguda o accidente isquémico transitorio
ITRM20100121A1 (it) * 2010-03-18 2011-09-19 Univ Pisa Marcatori molecolari per infezioni delle vie urinarie.
CN102305858B (zh) * 2011-07-26 2013-08-21 深圳市国赛生物技术有限公司 一种检测降钙素原的试剂盒
AU2013217935B2 (en) 2012-02-09 2018-05-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
RU2730836C2 (ru) 2014-08-14 2020-08-26 Мемед Диагностикс Лтд. Вычислительный анализ биологических данных с применением многообразия и гиперплоскости
EP3230740B1 (en) 2014-12-11 2025-05-21 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
CA2992343A1 (en) * 2015-07-13 2017-01-19 University Of Geneva Biomarker panels for brain injury complications
CA3015046A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
EP3440467B1 (en) * 2016-04-08 2020-05-13 Lunginnov Method for diagnosing postoperative pulmonary infections in patients who underwent surgery
CN107490679A (zh) * 2016-06-09 2017-12-19 常州博闻迪医药科技有限公司 一种唾液降钙素原酶联免疫检测方法
CN107490683A (zh) * 2016-06-09 2017-12-19 常州博闻迪医药科技有限公司 一种唾液降钙素原胶体金检测方法
WO2018011795A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018011796A1 (en) * 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
WO2018114044A1 (en) * 2016-12-22 2018-06-28 University Of Geneva Biomarker panels for brain injury complications
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
JP7366007B2 (ja) 2017-09-13 2023-10-20 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング プロアドレノメジュリンに基づく輸液療法のガイダンスのための方法
EP3682247B1 (en) 2017-09-13 2022-02-09 B.R.A.H.M.S GmbH Proadrenomedullin as a marker for abnormal platelet levels
EP3502706A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
WO2019122088A1 (en) * 2017-12-20 2019-06-27 B.R.A.H.M.S Gmbh Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
JP7344208B2 (ja) 2017-12-20 2023-09-13 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング pro-ADMに基づく抗生物質療法の指導
EP3578989A1 (en) 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients
WO2021083872A1 (en) 2019-10-28 2021-05-06 F. Hoffmann-La Roche Ag Sepsis management
KR102362951B1 (ko) * 2020-08-13 2022-02-14 연세대학교 원주산학협력단 프로칼시토닌 대 c­반응성 단백질의 비율을 이용한 허혈성 뇌졸중의 단기 사망률 예측 방법
JP2024516679A (ja) 2021-04-30 2024-04-16 エフ. ホフマン-ラ ロシュ アーゲー 敗血症の早期検出用のigfbp7マーカーパネル
CN117255947A (zh) 2021-04-30 2023-12-19 豪夫迈·罗氏有限公司 用于脓毒症的早期检测的sFlt1标志物组
CN117255948A (zh) 2021-04-30 2023-12-19 豪夫迈·罗氏有限公司 用于脓毒症的早期检测的pct标志物组
EP4330684A2 (en) 2021-04-30 2024-03-06 F. Hoffmann-La Roche AG Gdf15 marker panels for early detection of sepsis
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3147470A1 (de) 1981-12-01 1983-07-14 Bizerba-Werke Wilhelm Kraut GmbH & Co KG, 7460 Balingen Kraftmessvorrichtung
DE19600875C1 (de) * 1996-01-12 1997-06-26 Brahms Diagnostica Gmbh Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse
US5993811A (en) * 1997-02-03 1999-11-30 Biology Associates, Llc Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
DE112004001863T5 (de) * 2003-10-03 2006-09-07 Scantibodies Laboratory, Inc., Santee Verfahren und Verwendung von Bindungskomponenten zur Verbesserung der Testspezifität
CN101029897A (zh) * 2007-02-09 2007-09-05 深圳市新产业生物医学工程有限公司 一种降钙素原测试试剂盒及其测试方法
DE102007009751A1 (de) * 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
EP2167965B1 (de) * 2007-06-22 2013-04-10 B.R.A.H.M.S GmbH Verfahren zur detektion von analyten
EP2020603A1 (en) * 2007-08-03 2009-02-04 BRAHMS Aktiengesellschaft Method for risk stratification in stable coronary artery disease
ATE533061T1 (de) * 2007-08-03 2011-11-15 Brahms Gmbh Verfahren zur diagnose bakterieller infektionen
EP2101178A1 (en) * 2008-03-12 2009-09-16 BRAHMS Aktiengesellschaft Use of Procalcitonin (PCT) in prognosis following acute coronary syndromes
GB0722729D0 (en) * 2007-11-20 2007-12-27 Bristol Myers Squibb Co Diagnostic markers of wound infection
ES2601104T3 (es) * 2009-10-13 2017-02-14 B.R.A.H.M.S Gmbh Procalcitonina para el diagnóstico de infecciones bacterianas y la guía del tratamiento antibiótico en pacientes con apoplejía aguda o accidente isquémico transitorio

Similar Documents

Publication Publication Date Title
Jekarl et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis
AU2022228181B2 (en) Improved Methods and Devices for Accurate Diagnosis of Infections
RU2012142504A (ru) Прокальцитонин для диагностики бактериальных инфекций и контроля лечения антибиотиками для пациентов с неспецифическими жалобами
JP7579353B2 (ja) 重症急性呼吸器症候群(sars)における疾患進行を予後診断するためのプロアドレノメデュリン
JP2013527437A5 (cg-RX-API-DMAC7.html)
JP2023111913A (ja) pro-ADMに基づく抗生物質療法の指導
US20230176074A1 (en) Biomarkers for the diagnosis of respiratory tract infections
Liu et al. Procalcitonin as a diagnostic and prognostic marker for sepsis caused by intestinal infection: a case report
US10830774B2 (en) Methods and compositions for diagnosis and treatment of meningitis
US20250236913A1 (en) New method to diagnose inflammatory diseases
CN111094981B (zh) Pct和pro-adm作为监测抗生素治疗的标记物
BR112020004138A2 (pt) pro-adm como marcador de monitoramento terapêutico para pacientes doentes em estado crítico
CN104698159A (zh) 一种内毒素含量的检测方法
Jeon et al. The value of procalcitonin and the SAPS II and APACHE III scores in the differentiation of infectious and non-infectious fever in the ICU: a prospective, cohort study
RU2008123442A (ru) Способ определения ранних лабораторных маркеров генерализации инфекции у больных острым миелобластным лейкозом при нейтропении
Kassem et al. Comparative study of ascitic fluid and serum levels of calprotectin, procalcitonin and endocan in patients with liver cirrhosis for early diagnosis and prediction of spontaneous bacterial peritonitis
Şahintürk et al. Neutrophil-to-Lymphocyte Ratio as a Potential Early Marker of Antibiotic Resistance in Patients with Infected Cirrhotic Ascites.
Mandour et al. Neutrophil Gelatinase-Associated Lipocalin-2 and Macrophage Antigen-1 in Cirrhotic Patients Infected with Carbapenem Resistant Enterobacteriaceae
RU2820944C2 (ru) Проадм для прогнозирования риска состояния, требующего госпитализации, у пациентов с симптомами инфекционного заболевания
JP2013519083A5 (cg-RX-API-DMAC7.html)
Lei et al. Expression of Serum Immune Inflammatory Factors in Children with Suppurative Tonsillitis Caused by Adenovirus Infection and Its Correlation with Adenovirus Pneumonia
CN109959796A (zh) 一种人血清dkk1酶联适配体吸附检测试剂盒
Mutenta et al. The diagnostic value of Neutrophil Gelatinase–Associated Lipocalin (NGAL) for detecting early phase sepsis in patients with suspected bacterial infection.
CHOI et al. The clinical value of procalcitonin in diagnosis of patients with fever
WO2025202445A2 (en) Cxcr4 inhibitor compound in the treatment and/or the prevention of severe ards